Akorn, Inc. (AKRX) stock prices updated...

Akorn, Inc. stock price

Akorn, Inc. latest news:

  • 11/22/2017 01:31:57

    Fresenius says Akorn deal closure could take until next year

    FRANKFURT, Nov 22 (Reuters) - German healthcare group Fresenius SE said the planned takeover of Akorn , a U.S. maker of liquid generic drugs, might not be completed before next year as the U.S. antitrust review could take longer than expected.

  • 09/08/2017 12:08:06

    Allergan $13.75 mln agreement with Saint Regis Mohawk Tribe a play to protect key dry eye product

    Allergan PLC shares rose 1.8% in heavy Friday afternoon trade on news of an unorthodox agreement the company has made with the Saint Regis Mohawk Tribe that could protect patents on a key Allergan dry eye product, Restasis. Under the agreement, the Saint Regis Mohawk Tribe now owns patents on Restasis -- which are expected to expire at the end of August 2024 -- and has granted Allergan exclusive licenses on the product. The Saint Regis Mohawk Tribe is filing to dismiss patent challenges under the U.S. Patent and Trade Office's inter partes review process "based on their sovereign immunity from IPR challenges," Allergan said, although the agreement does not affect recent patent litigation in a Texas federal court. Teva Pharmaceutical Industries Ltd. , Mylan NV and Akorn Inc. have all filed IPR challenges related to Restasis. Allergan will pay the Saint Regis Mohawk Tribe $13.75 million upfront and $15 million in annual royalties; an Allergan spokesperson said the latter is for commercial rights to Restasis. The Saint Regis Mohawk Tribe and its lawyer approached Allergan about the agreement, according to a Friday Allergan statement, and there is case law precedent of universities using this approach. The Allergan agreement is "part of our overall economic diversification strategy," the Saint Regis Mohawk Tribal Council said in a statement. "We realize that we cannot depend solely on casino revenues and, in order for us to be self-reliant, we must enter into diverse business sectors to address the chronically unmet needs of the Akwesasne community; such as housing, employment, education, healthcare, cultural and language preservation." Allergan shares have lifted 1.2% over the last three months, compared to a 1.2% rise in the S&P 500 .Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Alarm.com Holdings, Inc.ALRM | Alaska Communications Systems Group, Inc.ALSK | Albany Molecular Research, Inc.AMRI | Alcentra Capital Corp.ABDC | Alcobra Ltd.ADHD | Alder BioPharmaceuticals, Inc.ALDR | Aldeyra Therapeutics, Inc.ALDX | Alexion Pharmaceuticals, Inc.ALXN | Alexza Pharmaceuticals, Inc.ALXA | Alico, Inc.ALCO |